Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients

Backus LI, Belperio PS, Shahoumian TA, Loomis TP, Mole LA. Real-world effectiveness and predictors of sustained virological response with all-oral therapy in 21,242 hepatitis C genotype-1 patients. Antivir Ther. 2017;22(6):481-493.

Publication Type:

Journal Article

Authors:

Backus, LI.; Belperio, PS.; Shahoumian, TA.; Loomis, TP.; Mole, LA.

Source:

Antivir Ther., Volume 22, Issue 6, p.481-493 (2017)

Notes:

[Epub ahead of print] PubMed PMID: 27934775

Cited On:

Treatment-Naive Genotype 1a Without Cirrhosis

Export Citation:

RIS Format

Top